New strategies for lowering the costs of antiretroviral treatment and care for people with HIV/AIDS in the United Kingdom by Gazzard B, Moecklinghoff C, Hill A

Get full text

Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic by Easterbrook, P, Yu, L, Goetghebeur, E, Boag, F, McLean, K, Gazzard, B

Simplified one-step antibody-HLA directed expansion of HIV-specific cytotoxic T lymphocytes: a system suited for use in vivo. by Stebbing, J, Gazzard, B, Patterson, S, Bower, M, Nelson, M, Epenetos, A, Ogg, G, Gotch, F, Savage, P

Changes in outcome of persons initiating highly active antiretroviral therapy at a CD4 count less than 50 Cells/mm3. by Porter, K, Walker, S, Hill, T, Anderson, J, Leen, C, Johnson, M, Gazzard, B, Walsh, J, Fisher, M, Orkin, C, Schwenk, A, Gilson, R, Easterbrook, P, Delpech, V, Sabin, C

Testing for HIV: concise guidance. by Palfreeman, A, Fisher, M, Ong, E, Wardrope, J, Stewart, E, Castro-Sanchez, E, Peto, T, Rogstad, K, Sheather, J, Gazzard, B, Pillay, D, O'Brien, J, Delpech, V, Lowbury, R, Fleet, R, Azad, Y, Lyall, H, Hardie, J, Adegbite, G, Rooney, G, Whitehead, R

EARLY AND NON-REVERSIBLE DECREASE OF CD161++/MUCOSAL ASSOCIATED INVARIANT T CELLS IN HIV INFECTION by Cosgrove, C, Ussher, J, Rauch, A, Gaertner, K, Kurioka, A, Huehn, M, Adelmann, K, Kang, Y, Fergusson, JR, Simmonds, P, Goulder, P, Hansen, T, Fox, J, Guenthard, H, Khanna, N, Powrie, F, Steel, A, Gazzard, B, Phillips, R, Frater, J, Uhlig, H, Klenerman, P

Early and nonreversible decrease of CD161++ /MAIT cells in HIV infection. by Cosgrove, C, Ussher, J, Rauch, A, Gärtner, K, Kurioka, A, Hühn, M, Adelmann, K, Kang, Y, Fergusson, JR, Simmonds, P, Goulder, P, Hansen, T, Fox, J, Günthard, H, Khanna, N, Powrie, F, Steel, A, Gazzard, B, Phillips, R, Frater, J, Uhlig, H, Klenerman, P